2-[1-(4,6-dichloro-1,3,5-triazin-2-yl)piperidin-4-yl]-5-methyl-1,3-benzoxazole
Structure Info
- Chemspace ID
- CSSB21332070393 (In-Stock Building Blocks)
- IUPAC Name
- 2-[1-(4,6-dichloro-1,3,5-triazin-2-yl)piperidin-4-yl]-5-methyl-1,3-benzoxazole
- Mol formula
- C16H15Cl2N5O
- Mol weight
- 364 Da
- Catalog Number(s)
- BBLS21332070393, EN300-55001611, bbls21332070393
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 4.71
- Heavy atoms count
- 24
- Rotatable bond count
- 2
- Number of rings
- 4
- Carbon bond saturation, Fsp3
- 0.375
- Polar surface area (Å)
- 68
- Hydrogen bond acceptors count
- 5
- Hydrogen bond donors count
- 0
![Chemical structure of 2-[1-(4,6-dichloro-1,3,5-triazin-2-yl)piperidin-4-yl]-5-methyl-1,3-benzoxazole (C16H15Cl2N5O) - CSSB21332070393](/st/structure/200/f89814b778b2ef6690d7d284975611d5/CC1%253DCC2%253DC%2528OC%2528%253DN2%2529C2CCN%2528CC2%2529C2%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN2%2529C%253DC1.png "C16H15Cl2N5O")
- Zoom the structure
- CSSB21332070393
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 455.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 477.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 498.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 519.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 541.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 1,063.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,572.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 2,331.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 2-[1-(4,6-dichloro-1,3,5-triazin-2-yl)piperidin-4-yl]-1,3-benzoxazole - CSSB21332062400](/st/structure/200/f398854c03982e80b1c500c81426bff5/ClC1%253DNC%2528%253DNC%2528Cl%2529%253DN1%2529N1CCC%2528CC1%2529C1%253DNC2%253DC%2528O1%2529C%253DCC%253DC2.png)
![Chemical structure of 2-[1-(4,6-dichloro-1,3,5-triazin-2-yl)piperidin-4-yl]-6-fluoro-1,3-benzoxazole - CSSB21332128084](/st/structure/200/7f51a4d4ebc44b9ae6c8fc259149b4ff/FC1%253DCC2%253DC%2528C%253DC1%2529N%253DC%2528O2%2529C1CCN%2528CC1%2529C1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1.png)
![Chemical structure of 2-[1-(4,6-dichloro-1,3,5-triazin-2-yl)piperidin-4-yl]-5-methyl-1,3-benzothiazole - CSSB21332146475](/st/structure/200/811cceca4622ed82613390c835f39c3b/CC1%253DCC2%253DC%2528SC%2528%253DN2%2529C2CCN%2528CC2%2529C2%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN2%2529C%253DC1.png)
![Chemical structure of 1-[4-(5-methyl-1,3-benzoxazol-2-yl)piperidin-1-yl]ethan-1-one - CSSB15093195422](/st/structure/200/635c763cd71f4a88e46aaf82a590a163/CC%2528%253DO%2529N1CCC%2528CC1%2529C1%253DNC2%253DCC%2528C%2529%253DCC%253DC2O1.png)
![Chemical structure of 2-[1-(4,6-dichloro-1,3,5-triazin-2-yl)pyrrolidin-3-yl]-1,3-benzoxazole - CSSB21332128098](/st/structure/200/666e060dea35b8b33d8a6f3637f518be/ClC1%253DNC%2528%253DNC%2528Cl%2529%253DN1%2529N1CCC%2528C1%2529C1%253DNC2%253DC%2528O1%2529C%253DCC%253DC2.png)
![Chemical structure of 2-[1-(4,6-dichloro-1,3,5-triazin-2-yl)piperidin-4-yl]-7-methyl-1,3-benzoxazole - CSSB21332069821](/st/structure/200/54c7172ca3c2a9f45b1a049122ad35b5/CC1%253DC2OC%2528%253DNC2%253DCC%253DC1%2529C1CCN%2528CC1%2529C1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1.png)
